Literature DB >> 12430592

Models for the spread of resistant pathogens.

B R Levin1.   

Abstract

I consider three mathematical models of the epidemiology of antibiotic treatment and the evolution of resistance. All of these models explore the relationship between the volume of antibiotic use and the frequency and rate of ascent (or descent) of resistance. The first model is in the population genetics tradition and assumes that in the absence of treatment the frequency of resistance wanes at a rate proportional to the fitness costs associated with resistance, but precipitously ascends to high frequencies in treated patients. The second two models are in the compartment, or SIR, model tradition of infectious disease epidemiology. The first of these considers the relationship between resistance and rates of antibiotic treatment in open communities. The second explores the factors contributing to the frequency of resistance in the closed settings of hospitals and nursing homes. While I give some consideration to the epidemiological and medical implications of the results of the analysis of the properties of these models, for the most part the models are the message. I end with a harangue about the utility of simple mathematics for these considerations and a plea to obtain realistic estimates of the parameters of these models and test the validity of the predictions generated from the analysis of these models.

Entities:  

Mesh:

Year:  2002        PMID: 12430592

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  14 in total

Review 1.  Translational systems approaches to the biology of inflammation and healing.

Authors:  Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

2.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 3.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

4.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  Isoniazid resistance and the future of drug-resistant tuberculosis.

Authors:  Ted Cohen; Mercedes C Becerra; Megan B Murray
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

6.  Salicylate Increases Fitness Cost Associated with MarA-Mediated Antibiotic Resistance.

Authors:  Tiebin Wang; Colin Kunze; Mary J Dunlop
Journal:  Biophys J       Date:  2019-07-10       Impact factor: 4.033

Review 7.  Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.

Authors:  Digby F Warner; Valerie Mizrahi
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Probability of emergence of antimalarial resistance in different stages of the parasite life cycle.

Authors:  Wirichada Pongtavornpinyo; Ian M Hastings; Arjen Dondorp; Lisa J White; Richard J Maude; Sompob Saralamba; Nicholas P Day; Nicholas J White; Maciej F Boni
Journal:  Evol Appl       Date:  2009-02       Impact factor: 5.183

9.  Error-prone initiation factor 2 mutations reduce the fitness cost of antibiotic resistance.

Authors:  Anna Zorzet; Michael Y Pavlov; Annika I Nilsson; Måns Ehrenberg; Dan I Andersson
Journal:  Mol Microbiol       Date:  2010-02-03       Impact factor: 3.501

10.  The skill and style to model the evolution of resistance to pesticides and drugs.

Authors: 
Journal:  Evol Appl       Date:  2010-03-29       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.